MedTrace Logo

A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke

NCT05496361 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 238

Last updated 2022-08-11

No results posted yet for this study

Summary

This is a prospective, randomized, single blind, concurrent controlled, multi-center study. Patients presenting with symptoms of acute ischemic stroke who have evidence of a large vessel occlusion in the cerebral circulation.

Conditions

  • AIS
  • Acute Ischemic Stroke
  • Large Vessel Occlusion
  • Thrombectomy

Interventions

DEVICE

Tianyi Revascularization Device

Revascularization Device using the Mechanical thrombectomy technique for recanalization of an occlusion large vessel in the brain

DEVICE

Solitaire FR Revascularization Device

Revascularization Device using the Mechanical thrombectomy technique for recanalization of an occlusion large vessel in the brain

Sponsors & Collaborators

  • Suzhou Zenith Vascular Scitech Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-24
Primary Completion
2021-11-24
Completion
2022-07-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05496361 on ClinicalTrials.gov